Magesh Ramasamy

Dr. Magesh Ramasamy

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
Udhaya Kumar. SUdhaya Kumar. S
Udhaya Kumar. S
DKD. Thirumal Kumar
D. Thirumal Kumar
RBR. Bithia
R. Bithia
SSSrivarshini Sankar
Srivarshini Sankar
MRMagesh Ramasamy
Magesh Ramasamy
HZHatem Zayed
Hatem Zayed
Background and Aims: Familial hypercholesterolemia (FH) is one of the major risk factor for the progression of atherosclerosis and coronary artery disease. This study focused on identifying the dysregulated molecular pathways and core genes that are differentially regulated in FH and to identify the possible genetic factors and potential underlying mechanisms that increase the risk to atherosclerosis in patients with FH. Methods: The Affymetrix microarray dataset (GSE13985) from the GEO database and the GEO2R statistical tool were used to identify the differentially expressed genes (DEGs) from the white blood cells (WBCs) of five heterozygous FH patients and five healthy controls. The interaction between the DEGs was identified by applying the STRING tool and visualized using Cytoscape software. MCODE was used to determine the gene cluster in the interactive networks. The identified DEGs were subjected to the DAVID v6.8 webserver and ClueGo/CluePedia for functional annotation, such as gene ontology (GO) and enriched molecular pathway analysis of DEGs. Results: We investigated the top 250 significant DEGs (p-value < 0.05; fold two change ≥ 1 or ≤ −1). The GO analysis of DEGs with significant differences revealed that they are involved in critical biological processes and molecular pathways, such as myeloid cell differentiation, peptidyl-lysine modification, signaling pathway of MyD88-dependent Toll-like receptor, and cell-cell adhesion. The analysis of enriched KEGG pathways revealed the association of the DEGs in ubiquitin-mediated proteolysis and cardiac muscle contraction. The genes involved in the molecular pathways were shown to be differentially regulated by either activating or inhibiting the genes that are essential for the canonical signaling pathways. Our study identified seven core genes (UQCR11, UBE2N, ADD1, TLN1, IRAK3, LY96, and MAP3K1) that are strongly linked to FH and lead to a higher risk of atherosclerosis. Conclusion: We identified seven core genes that represent potential molecular biomarkers for the diagnosis of atherosclerosis and might serve as a platform for developing therapeutics against both FH and atherosclerosis. However, functional studies are further needed to validate their role in the pathogenesis of FH and atherosclerosis.

3 June 2016 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
TKThirumal Kumar
Thirumal Kumar
George Priya Doss C.George Priya Doss C.
George Priya Doss C.
PSP. Sneha
P. Sneha
ITIftikhar Aslam ASLAM Tayubi
Iftikhar Aslam ASLAM Tayubi
SRSiva Ramamoorthy
Siva Ramamoorthy
MRMagesh Ramasamy
Magesh Ramasamy
Recent genetic studies have revealed the impact of mutations in associated genes for cardiac sarcomere components leading to dilated cardiomyopathy (DCM). The cardiac sarcomere is composed of thick and thin filaments and a giant muscle protein known as titin or connectin. Titin interacts with T-cap/telethonin in the Z-line region and plays a vital role in regulating sarcomere assembly. Initially, we screened all the variants associated with giant protein titin and analyzed their impact with the aid of pathogenicity and stability prediction methods. V54M mutation found in the hydrophobic core region of the protein associated with abnormal clinical phenotype leads to DCM was selected for further analysis. To address this issue, we mapped the deleterious mutant V54M, modeled the mutant protein complex, and deciphered the impact of mutation on binding with its partner telethonin in the titin crystal structure of PDB ID: 1YA5 with the aid of docking analysis. Furthermore, two run molecular dynamics simulation was initiated to understand the mechanistic action of V54M mutation in altering the protein structure, dynamics, and stability. According to the results obtained from the repeated 50 ns trajectory files, the overall effect of V54M mutation was destabilizing and transition of bend to coil in the secondary structure was observed. Furthermore, MMPBSA elucidated that V54M found in the Z-line region of titin decreases the binding affinity of titin to Z-line proteins T-cap/telethonin thereby hindering the protein–protein interaction.

1 May 2019 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
AAAshish Kumar Agrahari
Ashish Kumar Agrahari
George Priya Doss C.George Priya Doss C.
George Priya Doss C.
SRSiva Ramamoorthy
Siva Ramamoorthy
MRMagesh Ramasamy
Magesh Ramasamy
HZHatem Zayed
Hatem Zayed

6 November 2013 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
George Priya Doss C.George Priya Doss C.
George Priya Doss C.
BRB. Rajith
B. Rajith
CCChiranjib Chakraboty
Chiranjib Chakraboty
BVBalaji Medical Veeraraghavan
Balaji Medical Veeraraghavan
MRMagesh Ramasamy
Magesh Ramasamy
MDMaitreya Das
Maitreya Das
A major challenge remaining in drug design efforts towards protein kinase is due to the development of drug resistance initiated by the missense mutations in the kinase catalytic domain. Gain or loss of function mutations in the REarranged during Transfection (RET) tyrosine kinase gene have been associated with the development of a wide range of human associated cancers and Hirschsprung's disease. However, to what extent these mutations might affect bio-molecular functions remains unclear. In this article, the functionally significant mutations in RET were screened with the aid of various sequence and structure based in silico prediction methods. We mapped the deleterious mutants, modelled mutant proteins and deciphered the impact of mutations on drug binding mechanisms in the RET crystal structure of PDB ID: 2IVS with the potential inhibitor vandetanib by docking analysis. Furthermore, molecular dynamics simulations were undertaken to understand the mechanistic action of cancer associated mutations in altering the protein kinase structure, dynamics, and stability. According to our results, the overall effect of V804M, M918T and S922Y were destabilizing and mostly alter the electrostatic component of the binding energy. Specifically, the mutation of gatekeeper residue valine 804 present in the ATP binding pocket affects the protein stability and confers resistance to the drug vandetanib, which was consistent with previously published experimental results. Overall, our findings may provide useful structural insights for in-depth understanding of the molecular mechanism underlying RET mutation and developing effective drugs.

27 March 2021 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
Udhaya Kumar. SUdhaya Kumar. S
Udhaya Kumar. S
NPN. Madhana Priya
N. Madhana Priya
SNS. R. Nithya
S. R. Nithya
PKPriyanka Kannan
Priyanka Kannan
NJNikita Jain
Nikita Jain
George Priya Doss C.George Priya Doss C.
George Priya Doss C.

1 August 2019 in Phytomedicine
Verified
Journal Article
Closed access
VSV.L. Shailaja
V.L. Shailaja
VCV.S. Christina
V.S. Christina
CMC.D. Mohanapriya
C.D. Mohanapriya
PSP. Sneha
P. Sneha
RSR. Lakshmi Sundaram
R. Lakshmi Sundaram
MKMary Elizabeth Gnanambal. K
Mary Elizabeth Gnanambal. K